Chong Kun Dang Pharmaceutical : Decision on Cash Dividendsand Dividendsin Kind
March 10, 2022 at 03:03 am EST
Share
Decision on Cash Dividends and Dividends in Kind
1. Category of dividends
Year-end dividends
2. Types of dividends
Cash dividends
- Details of dividends in kind
-
3. Dividends per share (KRW)
Common stock
1,000
Different classes of stocks
-
- Differential dividends
No
4. Market price-dividend ratio (%)
Common stock
0.8
Different classes of stocks
-
5. Total amount of dividends (KRW)
11,238,797,000
6. Dividend record date
2021-12-31
7. Scheduled dividend payout date
-
8. Hosting shareholders' meeting?
Yes
9. Scheduled date of shareholders' meeting
2022-03-25
10. Date of board resolution (decision date)
2022-03-03
- Attendance of outside directors
Present (No.)
2
Absent (No.)
-
- Attendance of auditors (members of Audit Committee who are not outside directors)
Present
11. Other matters to be factored into investment decisions
- The information above is subject to change during the approval process of the general meeting of shareholders.
- The market price-dividend ratio in 4 above is the ratio of the dividend per share to the arithmetic average of the closing price, which was formed in the exchange market over one-week period until two transaction days prior to the closing date of the list of shareholders for calling the general shareholders' meeting.
- The scheduled dividend payout date of 7 above will be within one month of the general meeting of shareholders based on Article 464-2 of the Commercial Act
※ Related disclosure
-
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chong Kun Dang Pharmaceutical Corporation published this content on 10 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 March 2022 08:02:02 UTC.
Chong Kun Dang Pharmaceutical Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The company sells products in domestic and overseas markets.